StockWatch
·
Pharmaceuticals
Quarterly Result6 Mar 2026, 12:21 pm

Everest Organics Delays Q3 FY2025 Financial Results Submission: Here's Why

AI Summary

Everest Organics Ltd. has disclosed reasons for the delay in submitting its unaudited financial results for the quarter ended December 31, 2025. The Board Meeting, which started on February 14, 2026, at 8:45 PM and concluded on February 15, 2026, at 1:00 AM, required additional information before finalization. This led to the inability to submit the financial results within the 45-day period as per Regulation 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. However, the company uploaded the results on the BSE Listing Portal immediately after the Board Meeting, and the delay in submitting the explanation was unintentional. The company regrets the oversight and assures the Exchange of timely submission of all required disclosures in the future.

Key Highlights

  • Everest Organics delayed the submission of its Q3 FY2025 financial results.
  • The delay was due to detailed discussions and the need for additional information in the Board Meeting.
  • The company uploaded the results on the BSE Listing Portal immediately after the Board Meeting.
  • The delay in submitting the explanation was unintentional and regretted by the company.
  • Everest Organics promises timely submission of all required disclosures in the future.